{
    "2020-10-09": [
        [
            {
                "time": "2020-10-09",
                "original_text": "President Trump getting Regeneron treatment is 'wrong and unethical': Dr. Ezekiel Emanuel",
                "features": {
                    "keywords": [
                        "Trump",
                        "Regeneron",
                        "treatment",
                        "unethical"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Coronavirus Latest: Friday, October 9",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Latest"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Top Analyst Reports for Mastercard, JPMorgan & Eli Lilly",
                "features": {
                    "keywords": [
                        "Mastercard",
                        "JPMorgan",
                        "Eli Lilly",
                        "Analyst Reports"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Pharma Stock Roundup: LLY, AZN, PFE, GSK Progress on Coronavirus Programs",
                "features": {
                    "keywords": [
                        "LLY",
                        "AZN",
                        "PFE",
                        "GSK",
                        "Coronavirus",
                        "Progress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Eli Lily: Intriguing COVID-19 Story, but Questions Remain",
                "features": {
                    "keywords": [
                        "Eli Lily",
                        "COVID-19",
                        "Questions"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "HHS expects over 1 mln antibody doses from Regeneron, Lilly in 2020",
                "features": {
                    "keywords": [
                        "HHS",
                        "Regeneron",
                        "Lilly",
                        "antibody",
                        "doses"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Should You Invest in Regeneron, Lilly, or Gilead?",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Lilly",
                        "Gilead",
                        "Invest"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Need More Proof That Gileadâ€™s Treatment Helps Covid Patients? You Just Got It.",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Treatment",
                        "Covid",
                        "Proof"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-09",
                "original_text": "Lilly's OVERCOME Study Reveals Nearly 80% of People Reported Improvement in Their Migraine Since Starting a CGRP Monoclonal Antibody for Preventive Treatment",
                "features": {
                    "keywords": [
                        "Lilly",
                        "OVERCOME",
                        "Study",
                        "Migraine",
                        "Improvement",
                        "CGRP"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}